Products

N-Methyl-N-Benzylnitrosamine

    • Product Name: N-Methyl-N-Benzylnitrosamine
    • Alias: NMBA
    • Einecs: 204-828-6
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    963994

    Cas Number 13256-11-6
    Molecular Formula C8H10N2O
    Molecular Weight 150.18 g/mol
    Iupac Name N-Benzyl-N-methylnitrous amide
    Appearance Yellow oily liquid
    Boiling Point 105-107°C at 3 mmHg
    Density 1.08 g/cm³
    Solubility Soluble in organic solvents
    Synonyms N-Methyl-N-Benzyl Nitrosamine

    As an accredited N-Methyl-N-Benzylnitrosamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle containing 25 grams of N-Methyl-N-Benzylnitrosamine, tightly sealed with a screw cap, labeled with hazard information.
    Shipping N-Methyl-N-Benzylnitrosamine should be shipped in tightly sealed containers, protected from light, moisture, and incompatible substances. It must be packed in accordance with regulations for hazardous, carcinogenic chemicals, often under cooled conditions. Proper labeling and documentation are required, and only trained personnel should handle and transport this compound.
    Storage N-Methyl-N-Benzylnitrosamine should be stored in a tightly sealed container, away from light, heat, and sources of ignition, preferably in a cool, dry, and well-ventilated chemical storage area. It must be clearly labeled and kept separate from incompatible substances, such as strong acids and oxidizing agents. Use with proper personal protective equipment and follow all safety regulations due to its carcinogenicity.
    Application of N-Methyl-N-Benzylnitrosamine

    Applications of N-Methyl-N-Benzylnitrosamine in Industrial Manufacturing

    N-Methyl-N-Benzylnitrosamine serves as a key specialty intermediate within controlled industrial sectors. Below, we detail precise application areas, processing roles, and regulatory frameworks relevant to major downstream industries wherein manufacturers utilize this compound under strictly monitored conditions.

    1. Pharmaceutical Reference Material Synthesis

    Industrial laboratories use this nitrosamine as a highly specific reference or impurity marker for analytical trace determination within pharmaceutical QC. Operations integrating it must comply with international nitrosamine control standards, especially for small molecule synthesis involving alkylated aromatic amines. QC technicians dose tightly controlled microgram quantities into simulated matrices to validate LC-MS/MS assay parameters. Downstream steps include spiking, calibration curve generation, and recovery studies. Finished outputs consist of analytical reference kits for regulated pharmaceutical labs.

    Industry compliance standards

    • USP General Chapter <1469> (Nitrosamine Impurities)
    • ICH M7 Guidelines (Assessment and Control of DNA Reactive (Mutagenic) Impurities)
    • European Pharmacopoeia 2.5.42 (Nitrosamines in Active Substances)
    • GMP for Reference Standards (EU GMP Part II, Chapter 17)

    Typical usage ratio

    • 0.1–10 μg per analytical batch, adjusted based on matrix interference and detection limit requirements.

    Downstream process integration

    • Added during sample spiking, calibration standard preparation, and recovery testing by QC teams in pharmaceutical analytical development.

    Final product types

    • Pharmaceutical nitrosamine reference kits
    • Certified analytical standards for nitrosamines
    • Internal QC controls for API batch release
    • Matrix-matched calibration sets

    2. Carcinogenicity Mechanism Research Compounds

    Biomedical R&D institutions rely on this compound as a probe agent in mechanistic toxicity studies targeting DNA alkylation and metabolic activation pathways. Research chemists use it in regulated in vitro and in vivo test models governed by OECD guidelines. Strict dosing protocols call for freshly prepared solutions, followed by controlled incubation or injection phases. The resulting biological samples undergo LC/MS screening for mutagenicity markers, essential to toxicological risk assessments and safety dossier preparation for regulated industries.

    Industry compliance standards

    • OECD Test Guideline 471 (Bacterial Reverse Mutation Test)
    • OECD Test Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
    • GLP (Good Laboratory Practice, OECD Principles)
    • REACH Registration when handled above threshold quantities (EU No. 1907/2006)

    Typical usage ratio

    • Dosed at 0.01–1 mg/kg body weight in animal models; 0.01–10 μg/mL for cell culture bioassays, depending on protocol sensitivity and organism tolerance.

    Downstream process integration

    • Applied during induction phase of carcinogenicity/mutagenicity screening, prior to genomic and metabolic endpoint analysis.

    Final product types

    • Toxicology screening research samples
    • Preclinical mechanistic study reports
    • Biomarker assay datasets
    • Genotoxicity risk evaluation dossiers

    3. API Impurity Profiling in Bulk Drug Manufacturing

    Active pharmaceutical ingredient (API) manufacturers deploy N-Methyl-N-Benzylnitrosamine for batch-level impurity mapping and risk-based specification setting. During route scouting and scale-up, production chemists introduce trace residues into process validation streams to measure carrythrough, transformation, and final removal efficiency. This data supports stringent nitrosamine limit documentation in regulatory filings, essential for compliance during finished API supply to global pharmaceutical markets.

    Industry compliance standards

    • EMA Nitrosamine guidelines (EMA/409815/2020)
    • FDA: Control of Nitrosamine Impurities in Human Drugs
    • ICH Q3A (Impurities in New Drug Substances)
    • WHO GMP for APIs

    Typical usage ratio

    • Trace spiking at 0.1–10 ppm in process validation batches, ratio selected according to API-specific specification and method limit of quantitation.

    Downstream process integration

    • Added at pre-defined critical steps for stepwise impurity purge assessment within development and pilot-scale production workflows.

    Final product types

    • Impurity profiles and validation reports for APIs
    • Risk assessment documents for regulatory filings
    • Batch release specifications
    • Analytical validation protocols

    4. Environmental Nitrosamine Monitoring Systems

    Certified laboratories and regulatory authorities utilize this compound as a reference spike for nitrosamine quantification in environmental testing. Traceable standards are required for method validation in solid-phase extraction, water sample surveillance, and food contact material assessments. Analysts blend low-level dilutions into calibration sets, calibrate field testing equipment, and support nationwide monitoring campaigns mandated by environmental and food safety legislation.

    Industry compliance standards

    • EPA Method 521 (Nitrosamines in Drinking Water by Solid Phase Extraction and GC/MS)
    • EN 15891:2010 (Analysis of Nitrosamines in Water)
    • ISO/IEC 17025 Laboratory Accreditation
    • FDA Food Contact Notification Program (21 CFR 174-189, relevant to migration studies)

    Typical usage ratio

    • 0.2–20 ng/mL for water testing calibrations, with levels selected based on method sensitivity, detection window, and reporting threshold.

    Downstream process integration

    • Injected during test calibration, blank sample setup, QC spike validation, and recovery efficiency checks in automated analytical systems.

    Final product types

    • Certified environmental calibration standards
    • Field-ready water quality monitoring kits
    • Analytical method validation sets
    • Regulatory surveillance test reports

    5. Tobacco-Specific Nitrosamine Analytical Testing

    Tobacco analysis laboratories utilize this compound among a panel of structurally similar nitrosamines for quantitating carcinogenic impurities in cigarette filler, smoke condensate, and e-liquids. Strict sample prep SOPs and high-resolution chromatography ensure results comply with international reporting mandates. Cheminformatics experts dose standard mixes before automated extraction and multi-stage MS runs, supporting risk-based market surveillance and compliance for global manufacturers.

    Industry compliance standards

    • ISO 17025 (Accredited Testing Laboratories)
    • WHO TobReg Guidelines (Tobacco Specific Nitrosamines in Cigarette Filler and Smoke)
    • CORESTA Method No. 75 (Determination of Tobacco Specific Nitrosamines in Mainstream Cigarette Smoke)
    • US FDA Guidance for Industry – Tobacco Product Testing

    Typical usage ratio

    • 1–50 ng per analytical vial; standard concentrations selected by product matrix and method validation plan.

    Downstream process integration

    • Added into sample extraction solutions, spiking protocols, and calibration curve preparation prior to chromatographic quantification and reporting.

    Final product types

    • Tobacco specific nitrosamine reference solutions
    • Cigarette and e-liquid impurity test reports
    • International tobacco market safety compliance dossiers
    • Analytical performance monitoring records

    Free Quote

    Competitive N-Methyl-N-Benzylnitrosamine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    N-Methyl-N-Benzylnitrosamine: Practical Insights from the Manufacturer’s Bench

    Understanding N-Methyl-N-Benzylnitrosamine from the Ground Up

    On our plant floors, the details of every molecule count, and N-Methyl-N-Benzylnitrosamine (sometimes called NMBA or by its chemical formula C8H10N2O) makes no exception. Working day in and out with nitrosamine chemistry, we learn why some compounds find their way into basic research portfolios and specialty synthesis labs, while others stay on shelf for select projects. This compound stands out for more than just its name. Its structural features give it real-world significance for those investigating carcinogenic mechanisms, complex organic synthesis, or certain applications in chemical toxicology.

    Production Quality: Consistency Built Through Experience

    In the world of small-molecule chemical manufacturing, purity isn’t just about numbers on a certificate. Synthesis routes, choice of raw materials, and every cleanup step show up in the final chromatogram. N-Methyl-N-Benzylnitrosamine pushes us to streamline our oxidation, employ true anhydrous conditions, and run analytical checks after every stage. Our batches regularly achieve purity suitable for advanced research applications, and we subject each run to targeted impurity profiling, especially to screen for closely related nitrosamines which might otherwise escape routine detection.

    Researchers who work with nitrosamines need confidence in the chemical integrity of their samples. Inconsistencies in the nitroso group's integration into the N-methyl-N-benzylamine backbone shift both reactivity and safety outcomes. We’ve found that batch-to-batch comparison—not just a quick melting point or TLC check, but full NMR and HPLC analysis—eliminates unwelcome surprises for our clients and lets us stand by the real performance of our product.

    Model and Specifications: Beyond Simple Commodity Chemistry

    We synthesize N-Methyl-N-Benzylnitrosamine typically as a crystalline solid, and its presentation offers clean visual cues of quality. Typical melting point range sits close to literature values, sometimes showing a faint yellow hue due to nitrosamine chromophores. Analytical confirmation includes NMR spectra (with clear singlets for methyl, benzyl, and nitroso protons) and mass spectrometry. Each batch comes with supporting chromatographic and spectroscopic documentation from our own instrument suite; our chemists run every test with the same caution they expect in their own personal research.

    Customers sometimes ask about alternative grades. For this nitrosamine, we don’t cut corners with technical or crude grades, given that impurities in the nitroso family can confound toxicological studies. Samples can be provided as solution in certified solvents when users request it, minimizing handling risks and improving dosing accuracy for sensitive bioassays or analytical method development.

    Why Researchers Turn to N-Methyl-N-Benzylnitrosamine: Core Uses

    In our conversations with academic and industrial scientists, the value of N-Methyl-N-Benzylnitrosamine centers around its role as a well-characterized nitrosamine standard. Many regulatory agencies require manufacturers to monitor nitrosamine contamination, especially in pharmaceuticals where nitrosamines (even in trace amounts) have led to major recalls. Labs working on reference methods call on this molecule’s sharp probe for chromatographic and spectroscopic validation. It provides a model system to test new methods for sample cleanup or instrumental detection of nitrosamines.

    Beyond analytical reference, N-Methyl-N-Benzylnitrosamine’s manageable volatility and chemical stability make it handy for dose–response assays in animal carcinogenicity studies. Biological teams interested in DNA alkylation pathways use this molecule as a tool compound, often comparing metabolic outcomes with other aliphatic or aromatic nitrosamines. Because of its structural similarity to other regulated molecules, it serves as a relevant proxy without introducing excessive complexity to a study.

    Several contract research organizations working in environmental toxicology use it to screen new filtration and degradation techniques—especially when developing activated carbon processes for nitrosamine removal in water treatment. Chemical engineers have told us this nitrosamine’s well-characterized properties let them calibrate continuous removal columns with reproducible loadings and predict breakthrough curves without guesswork.

    On an organic synthesis bench, its reactivity profile gives chemists a chance to explore selective N-demethylation or reduction, providing case studies for new catalytic processes. Some groups turn to it as a nitrosating agent in controlled settings, tapping the specificity that a benzyl ring brings to the reaction profile.

    Real Differences From Other Nitrosamines

    To someone outside a chemistry lab, the differences between N-Methyl-N-Benzylnitrosamine and other nitrosamines might sound academic, but in production and downstream usage, these distinctions have practical weight. The methyl group increases water solubility modestly, making this molecule a better candidate for certain aqueous assays than its more hydrophobic relatives. The benzyl group’s presence strengthens its UV absorbance, offering reliable detection in HPLC or GC systems fitted with DAD or MS detectors.

    Many buyers familiar only with dimethylnitrosamine or diethylnitrosamine expect similar behavior. Yet, the interaction between N-methyl and N-benzyl substituents changes not just basic chemical stability, but decomposition rates under heat or acidic conditions. In a controlled stability study, our teams often observe N-Methyl-N-Benzylnitrosamine outperforming simpler nitrosamines in shelf storage, even in variable humidity. For research into structure–activity relationships, this unique skeleton delivers a teaching moment for medicinal chemists tracking nitrosamine risk in active pharmaceutical ingredients.

    From the manufacturer’s point of view, the synthetic route for N-Methyl-N-Benzylnitrosamine brings an extra challenge due to the benzyl group’s sensitivity to over-oxidation and the need for tailored workup conditions. This stands in contrast to the more direct synthetic strategies for producing dialkylnitrosamines, where the product often distills out as a liquid. As a result, our technical staff pay much closer attention, both at scaleup and during quality review. Our formulation chemists often recalibrate glassware cleaning processes after any run involving this material, since nitrosamines (including this one) pose a significant safety consideration. They linger, get into trace residues, and demand a much higher degree of diligence in cleaning validation.

    From an environmental standpoint, the breakdown products diverge as well. The benzyl group’s aromatic ring slows simple hydrolysis, giving a different pattern of metabolites in biological and non-biological settings. Those investigating wastewater treatment or toxicology can find concrete distinctions in recovery yields or persistence of breakdown products, which directly affect environmental risk assessments.

    Facing Safety and Regulatory Challenges

    Handling nitrosamines—including N-Methyl-N-Benzylnitrosamine—deserves the full attention of everyone on the team. Chemists in our facility spend real time training on careful technique and containment. The compound’s toxicity and carcinogenic potential set rules for batch processing and require process areas fitted with ventilation controls, double-glove protocols, and monitored storage. We invest in staff education, making sure no step gets overlooked, and keep our safety data material up-to-date based on the latest regulatory and research findings.

    Our own experience matches what regulatory agencies and published research have concluded: trace nitrosamines can slip into finished products unless raw material quality and handling rules are strictly maintained. This risk grows when synthesizing complex molecules or conducting downstream derivatizations using primary or secondary amines. As more industries (especially pharmaceutical manufacturers) tune their testing for nitrosamine content, our client base requires strict documentation and transparency for every material batch delivered. We built our process to trace the origin of every precursor and to offer validated chain-of-custody information on request.

    Regulatory alerts across North America, Europe, and Asia have forced the entire sector to rethink the way nitrosamines are managed throughout the value chain. Inspections are no longer rare, and unannounced audits expect comprehensive documentation—from production logs to disposal records. Our teams do not treat these as paperwork exercises; these practices directly lower risk, encourage real-time fixes, and improve confidence in shipping standards.

    Improving Manufacturing Outcomes: Less Hype, More Action

    In the crowded world of specialty chemicals, the only way to stay ahead is to put process knowledge into action. For N-Methyl-N-Benzylnitrosamine, this means working with chemistries that minimize byproduct formation from the ground up. Our R&D chemists have piloted alternative nitrosation conditions—moving away from excess nitrite salts in favor of more selective oxidizers. These changes not only cut down on environmental waste and cleaner batch runs, but also allow us to isolate smaller impurities before they can accumulate.

    Operational learning builds with each campaign. Meticulous control over reactor temperature, pH, and reagent order translates to better yield and lower side product. We employ targeted in-process controls and adjust protocols in response to analytical results, not out of routine but because small differences in intermediate quality ripple through the final product. Each time new research signals a potential impurity or process risk for nitrosamines, our teams set up test runs on a benchtop scale, audit the corresponding analytics, and update standard operating procedures as needed.

    Wastework is a manufacturing reality, and nitrosamines challenge everyone in the facility. Our solutions start with minimizing the presence of secondary amine byproducts, opting for closed-system liquid transfers and refining cleanup stages to scrub residuals. Since regulatory bodies focus on nitrosamine contamination even at parts-per-billion, we invest in state-of-the-art trace analysis tools. These upgrades are not window-dressing: more robust testing protects both our workplace and downstream users, closing the gap between lab results and operational integrity.

    Collaborative Solutions for Researchers and Manufacturers Alike

    Feedback from our partners shapes real product improvements. Customers in analytical chemistry need solvents pre-screened for trace contamination, and our team sources only suppliers who provide transparent contaminant data. In cases where end-users require solutions or dilutions at specific concentrations, we run small-batch customizations using our own traceable solvent stocks. Every change stands documented and cross-referenced with archived samples, so any anomaly gets traced and resolved.

    Open communication about storage, handling, and application lets end-users protect their staff and data quality. We often provide research groups with additional technical notes on proper storage conditions (ideally low temperatures and darkness to slow down thermal or photolytic degradation). Our lab staff shares lessons learned from their own experience about long-term sampling stability, especially for analytical reference applications.

    When we spot an emerging need—such as new analytical protocols for trace nitrosamines in food safety or the launch of new regulatory thresholds—we reach out to research clients before the guidelines are enforced. This direct connection brings tangible benefits: teams are ready, documentation matches new expectations, and research continues without delays brought by unexpected regulatory hurdles.

    Continuous Improvement Rooted in Real-World Feedback

    Making and supplying N-Methyl-N-Benzylnitrosamine puts us in contact with scientists driving change in risk assessment, analytical science, and process safety. Regular dialogue brings new insights—what works, where bottlenecks persist, and what data matters most on a day-to-day basis. We value these relationships because they drive improvements in how we synthesize, purify, and deliver every gram. Troubleshooting with our users uncovers subtle challenges: storage bottlenecks with high-humidity climates, degradation rates depending on packaging type, and unexpected matrix effects in analytical runs.

    We have built our systems to keep learning. Every product complaint or unexpected result sparks an investigation, and we tweak production or logistics wherever needed. The manufacturing team regularly revisits production protocols and coordinates with analytical teams to ensure any new trend—whether in regulation, science, or user needs—gets addressed promptly. If a client’s QC report flags an outlier, we rerun our own analysis, root out missing steps, and revise our documentation. This hands-on practice ensures future batches run more predictably and users see direct improvement, not empty promises.

    Shared Responsibility: Protecting Researchers, Workers, and End Users

    Safety in our plant extends beyond technical documentation. Every worker gets quarterly refreshers on nitrosamine handling and changing regulatory landscapes. We upgrade containment and tracking systems according to real-world feedback, keeping an eye on what will stand up under scrutiny from regulators or partner audits. Regular drills test our response to leaks, spills, or unexpected exposure, reducing both operational and long-term risk.

    We work closely with clients to share evolving guidance—everything from storage updates to changing analytical protocols and waste disposal practices. By keeping this conversation current, users meet new compliance challenges and protect their own labs from avoidable setbacks.

    Looking Ahead: Adapting to Shifting Demands

    The trace nitrosamine landscape continues to evolve, driven by both scientific discovery and expanding regulation. Our commitment as a manufacturer reflects not just technical expertise, but the willingness to rethink processes when old practice fails to meet new risks. We know that clean data, rigorous transparency, and a culture of adaptability are the only long-term answers for our team and our clients.

    N-Methyl-N-Benzylnitrosamine may seem like a niche compound, but what we have learned producing it ripples across our entire organization. Every improvement driven by this product ends up shaping our protocols for other high-risk molecules. Our goal is to support every research and industrial partner—not just with a batch of chemicals, but with insight and experience that drives real results.

    The real test for specialty manufacturers is not just how a product looks on a specification sheet, but how it integrates into the chain of discovery, safety, and regulatory preparedness. For N-Methyl-N-Benzylnitrosamine, we measure our impact by the confidence our clients place in our materials, the actionable data our quality systems provide, and the culture of safety and innovation we foster through every run.

    Top